Abstract The objective of the study is to investigate the alcoholic (AlcE) and aqueous (AqsE) extracts of stem bark of Erythrina indica (Papilionaceae) for hypoglycaemic effects in normal and diabetic rats. Diabetes was induced in rats by a single dose administration of alloxan (120 mg/ kg, i.p.) or by injecting dexamethasone (10 mg/kg, i.p.) for 10 days. In normal rats, AlcE and AqsE had significantly decreased the blood glucose level (BGL) in a dose dependent manner after repeated administration for 7 days. In alloxan-induced diabetic rats, both the extracts decreased blood sugar levels with significant improvement in glucose tolerance and body weight at the end of 1st, 2nd and 3rd week after test extract treatment. In case of dexamethasone induced insulin resistant diabetic rats, repeated administration of AlcE and AqsE inhibited the increase in blood glucose level and improved glucose tolerance induced by dexamethasone as compared to dexamethasone induced diabetic rats. These results suggest that both extracts possess hypoglycaemic activity in normal as well as in diabetic rats. Among AlcE and AqsE, AqsE possesses better hypoglycaemic activ-* Corresponding author. Tel.: +91 820 2922482x189; fax: +91 820
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Introduction
Diabetes mellitus is a metabolic disorder characterized by hyperglycaemia and alterations in carbohydrate, lipid and protein metabolism, associated with absolute or relative deficiencies in insulin secretion and/or insulin action (Valiathan, 1998) . The World Health Organization (WHO) estimates that more than 220 million people worldwide have diabetes and this number is likely to more than double by 2030 (WHO, 2009 ). The high prevalence of diabetes as well as its long-term complications has led to an ongoing search for hypoglycaemic agents (Nicasio et al., 2005) .
The treatment of hyperglycaemia in diabetic patients is directed towards achieving euglycemia and minimizes chronic complications by administering oral hypoglycaemic agents. Despite this, the steady rise of insulin resistance cases of NID-DM is causing grave concern among the physicians. Although a number of pharmacological approaches to the treatment of NIDDM are currently available, it is clear that none is ideal for the treatment of a great majority of NIDDM patients. Thus development of newer therapeutic approach remains highly desirable (Rao and Rao, 2001) . In view of the side effects associated with the treatment by insulin and synthetic drugs which are available at present, searching for effective and safer hypoglycaemic plant drugs is going on all over the world. Herbal medicines play a vital role in this part to prevent side effects (Suman et al., 2006) .
In the traditional system of Ayurvedic treatment, medicines consist of plant products, either a single drug or in combination with others, which are considered to be less toxic and are free from side effects compared to synthetic drugs. Since the time of Charka and Sushruta many herbal medicines have been recommended for the treatment of diabetes mellitus.
The fresh juice from the bark of Erythrina indica (Papilionaceae) is used by the tribals for the treatment of diabetes (Nadkarni and Nadkarni, 2000) . Recently, investigation on the plant E. indica indicates that it is used in Cameroonian folk medicine for the treatment of analgesic and microbial infections and was found to exhibit significant anticonvulsant and anxiolytic activity (Nkengfack et al., 2001; Pitchaiah et al., 2008) . The present study was aimed to perform a systematic study and to investigate the possible hypoglycaemic and antidiabetic activities of various extracts of E. indica in normal and in experimentally induced diabetes rats.
Materials and methods

Drugs
Glibenclamide tab. (Aventis Pharma Ltd., Mumbai, India); alloxan (Sigma-Aldrich, USA); dexamethasone sodium phosphate (Tridoss Laboratories Ltd., Mumbai, India); glucose estimation kit. (Span diagnostic Ltd., Surat, India) were used in this study. All the other solvents and chemicals used for extraction and phytochemical investigation were of analytical grade purchased from S.D. Fine Chemicals Pvt. Ltd., Mumbai, India.
Animals
Adult Wistar rats weighing (150-200 g) from Bioneeds, Neelamangla, Bangalore were used. All the animals were housed in the animal house of PES College of Pharmacy, Bangalore, and were maintained at a standard room temperature of 25 ± 1°C; relative humidity of 45-55% and a 12:12 h light/ dark cycle for 7 days with free access to standard rat pellet (Pranav Agro Industries Ltd., Bangalore, India) and water ad libitum under hygienic conditions. The animals were selected based on the model criteria and care was taken in such a way that all the animals were used only once. Animals were accustomed to laboratory conditions for 48 h before the initiation of experiment. The approval of the Institutional Animal Ethical Committee (IAEC) of PES College of Pharmacy, Bangalore (Karnataka) was taken before the initiation of the experiments. All the protocols and experiments were conducted in compliance with the ethical principles and guidelines provided by the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA), Chennai, India.
Preparation of extracts
Stem barks of E. indica Linn. were collected and was authenticated by Shiddamallayya N, Regional Research Institute (RRI), Jayanagar, Bangalore. The air-dried powdered material of 80 g was successively extracted by using Soxhlet apparatus, at 60-80°C with petroleum ether followed by alcohol (70%). The residue obtained from the first extract was air dried and then subjected for alcoholic extract.
Residue obtained from the alcoholic extract was then macerated with water for 72 h. All the extracts were then concentrated by distilling the solvent evaporating to dryness at low temperature. The extracts were weighed and the percentages of different extractive values were calculated in terms of air dried weight of the plant material.
Determination of acute toxicity (OECD, 2001)
The acute toxicity of alcoholic and aqueous extracts of E. indica were determined by using female albino Wistar rats (150-200 g) which were maintained under the standard conditions. The animals (n = 5 per dose) were fasted 12 h prior to the experiment, up and down procedures were adopted for toxicity studies. Animals were administered with single dose of extract of E. indica at a dose of 2000 mg/kg and observed for their mortality during 2 and 7 days study period (short term) toxicity and the dose increased up to 5000 mg/kg and were observed up to 7 days for their behavioural, economical and neurological profiles except slight depression in their activity.
2.5. Assessment of hypoglycaemic activity in normal rats (Kesari et al., 2006) Fasted rats were divided in to five groups consisting of six animals in each group. Groups 1 and 2 received distilled water and vehicle (3% (v/v) Tween 80 in distilled water), orally in a volume of 10 ml/kg, which served as normal control and vehicle control. Group 3 received Glibenclamide (5 mg/kg, p.o.) as a standard drug suspended in vehicle. AlcE and AqsE suspended in vehicle were administered at the doses of 200 and 400 m/kg, p.o. in a volume of 10 ml/kg to the rats of groups 4, 5, 6 and 7, respectively. Blood samples were collected from the tail vein or by retro-orbital puncture method just prior to and at 1, 2 and 4 h after dosing for acute studies and glucose was estimated. For sub-acute studies blood sample was removed on the 4th and 7th days after 16 h of overnight fasting for glucose level estimation.
Oral glucose tolerance test (OGTT) was carried by administering glucose (2 g/kg, p.o.), 30 min after the extract or standard drug administration after 7 days of pre-treatment period. Blood samples were collected from tail vein for glucose analysis prior to glucose administration (0 h) and at 1, 2 and 3 h after glucose loading.
2.6. Assessments of anti-diabetic activity in alloxan-induced diabetic rats (Kesari et al., 2006) Alloxan monohydrate was dissolved in saline and administered intravenously into fasted rats at a dose of 120 mg/kg body wt. The solution should be fresh and prepared just prior to the administration. The rats were given 5% (w/v) glucose solution in feeding bottles for next 24 h in their cages to prevent hypoglycaemia after alloxan injection. After 72 h rats with BGL greater than 200 mg/dl and less than 400 mg/dl were selected and observed for consistent hyperglycaemia (fasting blood glucose level greater than 200 mg/dl and lesser then 400 mg/dl) up to 7 days. Such animals were divided into seven groups as follows:
Group 1: Normal control (distilled water 10 ml/kg, p.o.). Blood samples were collected by retro-orbital puncture at 0, 1, 2, 4 and 8 h after the administration. The treatment was continued for the next 21 days and blood samples were collected on 4th, 7th, 14th and 21st days after 1 h administration. Blood glucose level (BGL) was estimated at various time intervals GOD/P.O.D. kit. Oral glucose tolerance test (OGTT) on day 21 was carried out. Body weight of all animals was measured on the 0, 4th, 7th, 14th and 21st days after 1 h of treatment with the extracts/Glibenclamide/vehicle. The percentage change of body weight was calculated from its initial weight.
Urine strip for glucose estimation contains 1.7% (w/w) glucose oxidase, 0.2% (w/w) peroxidase, 0.1% (w/w) potassium iodide, 71.8% buffer, 42.1% (w/w) non-reactive ingredients. Urine was collected on day 4, 7, 15 and 21 after administration of extracts/Glibenclamide/vehicle. The sugar level in urine was graded (DICL, Chennai). The colour intensity of strip depends on the concentration of glucose which was compared against the standard grade given on the packet.
2.6.1. Assessment of mortality rate in alloxan-induced diabetic rats Alloxan may cause severe ketoacidosis and may lead to death of animal. In view of this the mortality rate was monitored throughout the study. The % of mortality was calculated at the end of each week of treatment on 7th, 14th, 21st day.
2.7. Effect of E. indica extracts on dexamethasone induced insulin resistant diabetic rats (Shalam et al., 2006) Wistar rats of either sex weighing 170-220 g were divided into seven groups consisting of six animals per group. Groups 1 and 2 received only distilled water and vehicle (3% (v/v) Tween 80 in water). Group 3 received Glibenclamide (10 mg/kg, p.o.) which served as reference standard group. AqsE at the doses, 200 and 400 mg/kg were administered orally to the rats of groups 4 and 5, respectively. All the treatments were made for a period of 10 days. One hour after the test drug administration all the rats received dexamethasone (10 mg/kg, p.o.) daily for 10 days except group 1 which served as the normal control group. Blood samples were withdrawn from tail vein, to determine FBG and insulin levels, prior to and on 4th, 7th and 10th days after 1 h after dexamethasone treatment. Oral glucose tolerance test was also performed with a glucose loading in these rats on the 10th day.
Statistical analysis
The values were expressed as mean ± S.E.M. Data were analyzed using One-way ANOVA followed by Tukey test. One set of comparison was made. P value <0.05 was considered as significant.
Results
Preliminary phytochemical of E. indica
Phytochemical investigation of E. indica revealed that petroleum ether extract contains phytosterols and fixed oils. AlcE contains carbohydrates, alkaloids, flavonoids, saponins, phytosterols, phenolics and tannins, proteins and amino acids, fixed oils and fats. AqsE contains carbohydrates, alkaloids, flavonoids, glycosides, phytosterols, triterpenoids proteins and amino acids. The percentage yield of petroleum ether, alcoholic and aqueous extract were found to be 0.57, 9.5 and 5.87, respectively. The % yield of petroleum ether extract was not sufficient. Hence was not used for further experimentation.
Hypoglycaemic activity in normal rats
Fasting blood glucose (FBG) levels were within the range of 95-105 mg/dl in all the groups at 0 h. Single dose administration of AlcE and AqsE (200 and 400 mg/kg) did not significantly decrease the blood glucose level at various time intervals viz. 1, 2 and 4 h after treatment, indicating that the extracts could not produce significant hypoglycaemic activity after acute treatment (Table 1) . Repeated administration of AlcE and AqsE had significantly reduced the FBG on 4th day with 400 mg/kg and on 7th day with 200 and 400 mg/kg, indicating that the aqueous extract can produce hypoglycaemia on repeated administration (Table 2) . Glibenclamide (5 mg/kg) significantly reduced blood glucose level after single dose and repeated dose administration as compared to vehicle groups.
Administration of glucose (2 g/kg) to 7 days pretreated rats significantly suppresses the rise in BGL with AqsE at 1 and 2 h with 200 and 400 mg/kg and at 1 h with 200 mg/kg as compared with vehicle control. Glibenclamide (5 mg/kg) showed significant suppression in BGL rise at 1 and 2 h (Table 3) .
Anti-diabetic activity in alloxan-induced diabetic rats
Fasting blood glucose (FBG) levels in normal rats were in the range of 95-100 mg/dl. Treatment with alloxan (120 mg/kg, i.v.) had increased the blood glucose level (BGL) to a range of 250-270 mg/dl after 5 days. Single dose administration of AlcE and AqsE (200 and 400 mg/kg) did not significantly reduced the BGL in alloxan-induced diabetic rats, while Glibenclamide (5 mg/kg) significantly reduce the BGL at 1st, 2nd and 4th hour after single dose administration in alloxan-induced diabetic rats (Table 4) .
Repeated dose administration with alcoholic and aqueous extract (200 and 400 mg/kg) had progressively reduced the BGL in a dose dependent manner over a period of 3 weeks (Table 5) . However, animals treated with both the doses of alcoholic extracts showed a significant decrease (P < 0.05) in BGL on 4th, 7th, 14th and 21st days of treatment when compared to other groups of animals; similarly animals treated with aqueous extracts also showed a significant (P < 0.05) decrease in BGL compare to other groups. The data in Table 5 show that the aqueous extracts treatment for 21 days in diabetic rats has caused a reduction in BGL when compared to the alcoholic extract, indicating the potency of aqueous extract. These results indicate that E. indica possesses hypoglycaemic activity on repeated administration in alloxaninduced diabetic rats.
Repeated dose treatment with AlcE and AqsE (200 and 400 mg/kg, p.o.) for 3 weeks had significantly improved glucose tolerance as compared to diabetic control rats (Table 6 ). Treatment with alloxan (120 mg/kg, i.v.) had significantly decreased the body weight at the end of 7th, 14th and 21st days as compared to normal animals. Repeated administration of Glibenclamide (5 mg/kg) had prevented the reduction in body weight on 4th, 7th, 14th and 21st day in diabetic rats. These results concluded that AqsE (200 and 400 mg/kg) and AlcE at 400 mg/kg were able to significantly inhibit the body weight only after the 14th day, whereas with AlcE 200 mg/kg, a significant decrease in body weight was seen on the 21st day (Table  7) . Values are expressed as mean ± S.E.M. n = 6. P values were analysed using One-way ANOVA followed by post hoc Dunnett's test. * P < 0.05 versus the vehicle treated control group. Values are expressed as mean ± S.E.M. n = 6. P values were analysed using One-way ANOVA followed by post hoc Dunnett's test. * P < 0.05 versus the vehicle treated control group.
Single administration of alloxan (120 mg/kg, i.v.) had produced mortality of 43% over a period of 3 weeks. Repeated administration of Glibenclamide (5 mg/kg) had prevented the mortality in alloxan-induced diabetic rats throughout the study. Repeated dose administration of AlcE (200 and 400 mg) showed mortality of 29% while AqsE at 400 mg/kg dose level showed 14% mortality rate at the end of 3 weeks. These results indicated that Glibenclamide and E. indica could protect the animals against alloxan induced mortality.
Urine sugar grade in alloxan-induced diabetic rats
After administering the alloxan at a single dose of (120 mg/kg, i.v.) the urine sugar level was grade 1 (+++) after 7 days and it was raised to grade 2 (++++) within a week's period. The standard Glibenclamide had reduced the urine sugar level from grade 0.25 (+) to grade 0.1 (+/2) on the 7th day and no sugar on the 14th and 21st days. In case of the AqsE (400 mg/kg) the urine sugar level was reduced from grade 0.25 (+) to grade 0.1 (+/2) on the 14th day and on the 21st day no urine sugar level was found. The results are summarized in Table 8 .
Effect of extracts of E. indica on BGL on repeated dose administration in dexamethasone induced insulin resistance diabetes in rats
Administration of dexamethasone for 10 days found to significantly increase serum glucose level from 140 to 200 mg/dl compared to normal control. The aqueous extract 200 mg/kg along with dexamethasone for 10 days had significantly (P < 0.05) reduced BGL on 4th, 7th and 10th days compared Values are expressed as mean ± S.E.M. n = 6. P values were analysed using One-way ANOVA followed by post hoc Dunnett's test. * P < 0.05 versus the vehicle treated control group. Values are expressed as mean ± S.E.M. n = 6. P values were analysed using One-way ANOVA followed by post hoc Tukey's test. * P < 0.05 versus the vehicle treated control group. Values are expressed as mean ± S.E.M. n = 6. P values were analysed using One-way ANOVA followed by post hoc Tukey's test. * P < 0.05 versus the vehicle treated control group. Values are expressed as mean ± S.E.M. n = 6. P values were analysed using One-way ANOVA followed by post hoc Tukey's test. * P < 0.05 versus the vehicle treated control group. Values are expressed as mean ± S.E.M. n = 6. P values were analysed using One-way ANOVA followed by post hoc Tukey's test. * P < 0.05 versus the vehicle treated control group. Values are expressed as mean grade ± S.E.M. n = 6. ++++ = 2. +++ = 1. ++ = 0.5. + = 0.25. +/2 = 0.1. Values are expressed as mean ± S.E.M. n = 6. P values were analysed using One-way ANOVA followed by post hoc Dunnett's test. * P < 0.05 versus the vehicle treated control group.
to dexamethasone treated group (diabetic control) similarly aqueous extract 400 mg/kg reduced more significantly (P < 0.05) in glucose level at the 10th day compare to other groups ( Table 9 ). The aqueous extracts (200 and 400 mg/kg) on repeated administration significantly reduced the increase in BGL in OGTT at 1, 2, 3 and 6 h compared to other groups (Table 10) .
3.4.1. Change in body weight in dexamethasone induced diabetic rats Dexamethasone caused weight reduction which was prevented significantly (P < 0.05) by the aqueous (200 and 400 mg/kg) extract of E. indica after 10 days of treatment compared with diabetic control and standard Glibenclamide treated animals.
Discussion
The present study was aimed at discovering the anti-diabetic properties of E. indica in alloxan induced diabetes and dexamethasone induced insulin resistance. In the ancient days E. indica was used alone or in combination with other remedial measures against diabetes mellitus. Alloxan causes a massive reduction in insulin release by the destruction of the b-cells of the islets of langerhans, inducing hyperglycaemia (Fisher, 1985) . The diabetic rats (induced by alloxan) showed a persistent rise in BGL after 7 days with the characteristic features of diabetes mellitus. Traditional plant medicines are used throughout the world for a range of diabetic presentations the study of such medicines might offer a natural key to unlock a diabetologist's pharmacy for the future. In light of this we made an attempt for the first time to study the effect of E. indica in normoglycaemic and hyperglycaemic rats. Both the extracts of E. indica were not able to decrease the BGL in alloxan-induced diabetic rats, on single dose administration which infers that the extracts are ineffective. The significant activity was attained on repeated administration of the AlcE and AqsE from day 7 by controlling the elevated BGL compared with other group. In case of OGTT, both the extracts on repeated administration improved glucose tolerance in diabetic rats on 8th, 15th and 22nd days as compared to diabetic control. While in case of AqsE (400 mg/kg) it has shown a significant reduction in the 6th hour and on 22nd hour to that of the standard. Impaired glucose tolerance is attained due to lack of insulin in alloxan-induced diabetic rats by destructing the b-cells which leads to type I diabetes (Tanga et al., 2006) . From the present study it indicates that these extracts can improve the glucose tolerance, suggesting that these extracts may show insulin mimetic activity or improved glucose utilization mechanism. Glucosuria is the common symptom of diabetes. It arises due to the increase in BGL above 250 mg/dl in diabetic animals. In our study we found that the administration of both extracts to diabetic rats reversed their blood glucose which was also reflected in their urine sugar levels. The possible mechanism by which the extracts bring about their anti-hyperglycaemic action may be by increasing either pancreatic secretion of insulin from b cells or its release from the bound form (Stanely et al., 2004) . It is well established that sulfonylureas produce hypoglycaemia by increasing the secretion of insulin from pancreas and these compounds are active in mild alloxan induced diabetes, whereas they are inactive in intense alloxan diabetes (nearly all the beta cells have been destroyed) (Krishna et al., 2004) . In our work, no histological study was carried out to explain the mechanism of anti-diabetic action of E. indica. However, our results showed that Glibenclamide reduced BGL in mild hyperglycaemic animals. The diabetic rats receiving the extracts of E. indica showed normalization of BGL compared to diabetic control. This could be due to the possibility that some beta cells are still surviving to exert their insulin releasing effect by E. indica. Moreover, extracts produced hypoglycaemia in normal rats also. This suggests that extracts are probably mediated by enhanced secretion of insulin like, sulfonylureas.
However, the possibility of enhanced tissue uptake by E. indica cannot be ruled out. In addition, the glucose lowering effect of extracts was more powerful when compared to normal rats suggesting that it could be caused by an increase in peripheral glucose consumption, this reinforces the hypothesis that the hypoglycaemic mechanism involves insulin like effect through peripheral glucose consumption, delay in insulin catabolism or inhibition of glucose reabsorption by the kidney. The fact that some herbal preparations enhances the beta cell regeneration and peripheral glucose utilization in Alloxan and Streptozotocin induced diabetic rats supports the above assumption (Chakravarthy et al., 1982; Mitra et al., 1996) . Oleanolic acid, a triterpenoids obtained from the stem bark lowers the blood glucose in normal and diabetic mice. It is well known that oxygen free radicals are involved in diabetogenic action of alloxan and plants containing flavonoids, isoflavanoids, triterpenoids have been shown to be effective in diabetes due their antioxidants property (Jafri et al., 2000; Syed et al., 2005) . This suggest that the anti-hyperglycaemic activity of E. indica may be due to free radical scavenging activity which enhance the beta cell regeneration against alloxan induced free radicals. However, from the present experimental data it is difficult to Values are expressed as mean ± S.E.M. n = 6. P values were analysed using One-way ANOVA followed by post hoc Dunnett's test. * P < 0.05 versus the vehicle treated control group.
say how exactly the mechanism of anti-diabetic activity of extracts of E. indica. It needs more elaborate study. One of the major complication of type I diabetes is weight loss. It arises due to the impairment in insulin action in the conversion of glucose into glycogen and catabolism of fats, inhibition of lipolysis due to its unavailability because of destruction in beta cells (Gillespie, 2006) . Due to this there will be a decrease in the body weight of the animals and in death. Treatment with extracts AlcE and AqsE has substantially prevented the body weight loss and mortality produced by alloxan. The results of BGL, glucose tolerance, urine sugar, body weight and mortality are in correlation with each other and indicate the AqsE and AlcE can be beneficial in reducing the effects of alloxan induced diabetes.
Dexamethasone results in hyperglycaemia due to an imbalance of lipid metabolism leading to hyperlipidemia and an increase in glucose level leading to hyperglycaemia. Dexamethasone can cause metabolic changes resulting in decrease in food consumption and decrease in body weight. Profound obesity due to alteration of ob gene expression often associated with development of insulin resistance with enhanced BGL due to impairment of GLUT4 translocation (Barbera et al., 2001; Ogawa et al., 1992) . In the present study treatment with dexamethasone for 10 days increases in BGL and decreases the body weight similar to that of the previous studies. Pretreatment with AqsE (200 and 400 mg/kg) 1 h before dexamethasone for 10 days had significantly prevented the rise in BGL caused by dexamethasone and also improved glucose tolerance after glucose loading. AqsE (200 and 400 mg/kg) significantly prevented the decrease in body weight as compared with diabetic control.
Conclusion
In conclusion, AqsE had shown a significant hypoglycaemic activity in normal rats, anti-diabetic activity against alloxan induced and improved insulin resistance in dexamethasone induced diabetic rats.
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